Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117240) titled 'Efficacy and Safety of Minocycline in Patients with Acute Spontaneous Intracerebral Hemorrhage' on Jan. 21.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Beijing Tiantan Hospital, Capital Medical University
Condition:
Intracerebral Hemorrhage
Intervention:
Minocycline placebo-control group:Oral Minocycline placebo
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-01-31
Target Sample Size: Minocycline placebo-control group:596;Minocycline treatment group:596;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.ht...